Sunshine Biopharma Inc. Salary and Wage, Excluding Cost of Good and Service Sold
Sunshine Biopharma Inc. (SBFM) reported Salary and Wage, Excluding Cost of Good and Service Sold of $593.84 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SalariesWagesAndOfficersCompensation · last filed 2026-08-13
- Sunshine Biopharma Inc. salary and wage, excluding cost of good and service sold for the quarter ending 2026-06-30 was $593.84K, a 13.22% increase year-over-year.
- Sunshine Biopharma Inc. salary and wage, excluding cost of good and service sold for the quarter ending 2026-03-31 was $251.16K, a 6.80% decline year-over-year.
- Sunshine Biopharma Inc. salary and wage, excluding cost of good and service sold for the quarter ending 2025-06-30 was $524.50K.
- Sunshine Biopharma Inc. salary and wage, excluding cost of good and service sold for the quarter ending 2025-03-31 was $269.50K, a 2.67% increase year-over-year.
- Sunshine Biopharma Inc. salary and wage, excluding cost of good and service sold for fiscal 2025 was $1.43M, a 22.93% decline from fiscal 2024.
- Sunshine Biopharma Inc. salary and wage, excluding cost of good and service sold for fiscal 2024 was $1.85M, a 22.13% increase from fiscal 2023.
- Sunshine Biopharma Inc. salary and wage, excluding cost of good and service sold for fiscal 2023 was $1.51M, a 15.13% decline from fiscal 2022.
- Sunshine Biopharma Inc. salary and wage, excluding cost of good and service sold for fiscal 2022 was $1.78M, a 500.39% increase from fiscal 2021.
| Period end | Salary and Wage, Excluding Cost of Good and Service Sold 3 month | Salary and Wage, Excluding Cost of Good and Service Sold 3 month as first filed | Salary and Wage, Excluding Cost of Good and Service Sold 6 month | Salary and Wage, Excluding Cost of Good and Service Sold 9 month | Salary and Wage, Excluding Cost of Good and Service Sold 9 month as first filed | Salary and Wage, Excluding Cost of Good and Service Sold 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $593.84K 10-Q · filed 2026-08-13 | $845.00K 10-Q · filed 2026-08-13 | ||||
| 2026-03-31 | $251.16K 10-Q · filed 2026-05-13 | |||||
| 2025-12-31 | $1.43M 10-K · filed 2026-04-03 | |||||
| 2025-06-30 | $524.50K 10-Q · filed 2026-08-13 | $988.80K 10-Q · filed 2026-08-13 | ||||
| 2025-03-31 | $269.50K 10-Q · filed 2026-05-13 | |||||
| 2024-12-31 | $1.85M 10-K · filed 2026-04-03 | |||||
| 2024-03-31 | $262.49K 10-Q · filed 2024-05-20 | $487.49K derived: sum of 2 quarters · filed 2025-04-01 | $732.49K derived: sum of 3 quarters · filed 2025-04-01 | $957.49K derived: sum of 4 quarters · filed 2025-04-01 | ||
| 2023-12-31 | $225.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-01 | $470.00K derived: sum of 2 quarters · filed 2025-04-01 | $695.00K derived: sum of 3 quarters · filed 2025-04-01 | $1.51M 10-K · filed 2025-04-01 | ||
| 2023-09-30 | $245.00K 10-Q · filed 2023-11-13 | $470.00K derived: sum of 2 quarters · filed 2023-11-13 | $1.29M 10-Q · filed 2023-11-13 | $2.30M derived: sum of 4 quarters · filed 2024-05-20 | ||
| 2023-06-30 | $225.00K 10-Q · filed 2023-08-10 | $1.04M 10-Q · filed 2023-08-10 | $2.06M derived: sum of 3 quarters · filed 2024-05-20 | $2.42M derived: sum of 4 quarters · filed 2024-05-20 | ||
| 2023-03-31 | $820.00K 10-Q · filed 2024-05-20 | $1.83M derived: sum of 2 quarters · filed 2024-05-20 | $2.20M derived: sum of 3 quarters · filed 2024-05-20 | $2.44M derived: sum of 4 quarters · filed 2024-05-20 | ||
| 2022-12-31 | $1.01M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $1.38M derived: sum of 2 quarters · filed 2024-03-28 | $1.62M derived: sum of 3 quarters · filed 2024-03-28 | $1.78M 10-K · filed 2024-03-28 | ||
| 2022-09-30 | $362.50K 10-Q · filed 2023-11-13 | $595.00K 10-Q · filed 2022-11-07 | $602.50K derived: sum of 2 quarters · filed 2023-11-13 | $770.10K 10-Q · filed 2023-11-13 | $1.09M 10-Q · filed 2022-11-07 | $1.04M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $240.00K 10-Q · filed 2023-08-10 | $510.00K 10-Q · filed 2023-08-10 | $677.31K derived: sum of 3 quarters · filed 2023-08-10 | $782.31K derived: sum of 4 quarters · filed 2023-08-10 | ||
| 2022-03-31 | $270.00K 10-Q · filed 2023-05-10 | $320.00K 10-Q · filed 2022-05-06 | $437.31K derived: sum of 2 quarters · filed 2023-05-10 | $542.31K derived: sum of 3 quarters · filed 2023-05-10 | $567.31K derived: sum of 4 quarters · filed 2023-05-10 | |
| 2021-12-31 | $167.31K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-04 | $272.31K derived: sum of 2 quarters · filed 2023-04-04 | $297.31K derived: sum of 3 quarters · filed 2023-04-04 | $297.31K 10-K · filed 2023-04-04 | ||
| 2021-09-30 | $105.00K 10-Q · filed 2022-11-07 | $130.00K derived: sum of 2 quarters · filed 2022-11-07 | $130.00K 10-Q · filed 2022-11-07 | |||
| 2021-06-30 | $25.00K 10-Q · filed 2022-08-03 | $125.93K 10-Q · filed 2022-08-03 | ||||
| 2021-03-31 | $109.93K 10-Q · filed 2022-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |